Cibc World Markets »

Denali Therapeutics shares owned by Cibc World Markets

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Cibc World Markets from 13F filings

Historical chart of Cibc World Markets investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Cibc World Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Cibc World Markets

Quarter filed Position value Share count Share price at filing
2025-06-30 $228k 16k 13.99
2025-03-31 $375k 28k 13.60
2024-12-31 $237k 12k 20.38